Objectives: To evaluate the complications, and visual and graft survival outcomes in eyes that had undergone penetrating keratoplasty (PKP) for keratoconus.
Introduction
In keratoconus, the cornea progressively thins and steepens, leading to the development of myopia and irregular astigmatism and, eventually, to the loss of best spectacle-corrected visual acuity (BSCVA); this noninflammatory ecstatic corneal disorder occurs naturally and is characterized as bilateral but asymmetrical. (1) Various therapeutic modalities for this disorder exist, including spectacles, contact lenses, lamellar keratoplasty (LK), penetrating keratoplasty (PKP), and, recently, intracorneal rings (ICRs). (1, 2) The type of treatment chosen depends on the severity of the disorder. In patients with keratoconus who have contact lens failure or apical scarring, PKP is a well-accepted treatment. (2, 3) Previous researches have revealed that keratoconus is one of the leading indications for corneal transplantation in Saudi Arabia and throughout the world. (3, 13) The purpose of this retrospective study is to determine the outcomes of a series of consecutive PKPs performed for patients with keratoconus at King Kahled Eye Specialist Hospital in Riyadh, Saudi Arabia.
Methods
After approval was obtained from the Institutional Review Board, a retrospective review was conducted of the medical records of all patients with keratoconus who had undergone PKP from January 
Results
Of the 311 patients with keratoconus who underwent PKP, there were 199 men (64.0%) and 112 women (36.0%). In 145 cases (46.6%), the procedure was performed on the right eye, and in 166 cases (53.4%) on the left eye. The mean age at time of surgery was 23.72 years (range, 10-62 years; SD, 6.39). The mean period of follow-up after PKP was 40.67 months (range, 2.10-65.77 months; SD, 14.45). Five patients had previously undergone cataract extraction surgery. The mean host corneal bed size was 7.44 mm (median, 7.50 mm; range, 6.0-8.30 mm), and the mean donor corneal button size was 7.68 mm (median, 7.75 mm; range, 6.0-8.5 mm). The most common host corneal bed sizes were 7.50 mm, used in 160 eyes (51.45%), and 7.00 mm, used in 74 eyes (23.8%). The most common donor graft button sizes were 7.75 mm, used in 154 eyes (49.52%), and 7.25 mm and 7.50 mm, used in 53 eyes (17.0%) and 41 eyes (13.18%), respectively. Graft-host disparity was ≤0.25 mm in 286 eyes (92.0%), and >0.25 mm in 25 eyes (8.0%) ( Table 1) . Surgical procedures had previously been performed on 10 eyes (3.2%) (5 cataract surgeries, 7 others). At the time of PKP, concomitant cataract extraction and intraocular lens (IOL) implantation were performed on only 1 patient; planned surgical iridotomy was also performed on 2 patients.
At the last follow-up visit, 212 eyes (68.2%) had a BCVA of 20/40 or better, 87 eyes (28.0%) were between 20/50 and 20/180, and 12 eyes (3.9%) were 20/200 or worse. Table 2 shows a statistically significant difference between preoperative and postoperative BCVA values of patients (P = 0.00) (Figure 1 ). All eyes with graft failure had VA values that were equal to or less than 20/200.
At the most recent visit, 305 grafts (98.1%) were clear, and only 6 grafts (1.9%) had failed. The mean time to graft failure was 23.62 months (range, 2.63-44.7 months) after transplantation. The overall probabilities of graft survival were 99.8% at 1 year and 97.6% at 5 years (Figure 2) . At least one episode of a rejection reaction occurred in 21 eyes (6.8%) of 311 eyes, with 3 eyes (0.96%) developing irreversible graft failure (P = 0.009). Of 218 eyes with a recipient size of ≥7.5 mm, 15 eyes (6.9%) developed a graft rejection episode compared with 6 eyes (6.45%) of 93 eyes with a recipient size of <7.5 mm, which is not statistically significant (P > 0.05).
Logistic regression with adjustment for intereye dependence revealed that age (hazard ratio, 1.05; 95% confidence interval [CI], 0.95-1.18; P = 0.33), gender (hazard ratio, 3.4; 95% CI, 0.38-30.12; P = 0.28), recipient size (hazard ratio, 2.73; 95% CI, 0.24-31.50; P = 0.422), and postoperative glaucoma (hazard ratio, 0.00; P = 0.99 ) were not significantly associated with graft failure. A significant association was found between rejection and graft failure (hazard ratio, 7.86; 95% CI, 1.27-48.66; P = 0.027). None of the eyes had cataract. At a mean time of 28 months after surgery, 7 eyes (2.3%) developed glaucoma escalation; however, none of these patients had a family history of glaucoma or had a failed graft. Control of intraocular pressure was achieved with the administration of topical medications in 7 eyes, and only 1 eye required a trabeculectomy.
Discussion
The number of keratoconus surgeries being performed in Saudi Arabia is rising. This rise has been attributed to population explosion, better patient access, improved healthcare availability, and an increased availability of grafts. (7) The demographic data for patients with keratoconus who underwent PKP in the present study are generally consistent with those from previous reports. (14) (15) (16) In this study, PKP was performed in relatively young patients (mean age was 23.72 years at the time of PKP), with a male predominance of 64.0%. In a study by Javadi et al, (16) the mean age at the time of surgery was 28.2 years, with 73.2% of patients being male. However, de Lavalette et al (17) reported a female predominance of 65% in their study. Various studies have reported that keratoconus has an equal prevalence in both genders, (1, 18) a greater prevalence in males, (14) (15) (16) 19) and a greater prevalence in females. (20) One possible reason for the increased relative frequency of male subjects undergoing transplantation compared with female subjects is an increased tendency for males to receive surgical treatment so as to improve occupational performance.
The graft survival rate of 98.1% in this series compares favorably to the results of previous series. (14-17, found a 5-year graft survival rate of 98% among patients who underwent PKP for keratoconus. In the present study, complications other than graft rejection were not significantly related to graft failure after PKP (P = 0.511). Of the 311 eyes in this study, 21 eyes (6.8%) had rejection episodes, and 3 eyes (0.96%) developed irreversible graft failure. This rate of rejection episodes is lower than in other series. For instance, Watson et al (23) reported 11 rejection episodes in 22 patients who underwent PKP, and Troutman and Lawless (8) reported a rejection rate of 18.5%. There was no significant difference in graft failure rates between male and female patients in any age group. In the current series, donor-recipient disparity had no effect on survival outcome.
The prognosis for graft survival in patients with keratoconus is considered excellent if surgery is performed on young patients who are highly motivated and compliant and who do not have other conditions that compromise visual potential (eg, age-related retinal disease). The 5-year Kaplan-Meier survival rate in the present series of 97.6% is comparable to those of other series.
(24,25) Age, gender, and recipient size did not contribute to an increased risk of graft failure after PKP in the present study's patients.
The mean BSCVA at the last visit was 20/30, which is within the range of 20/25 to 20/32 in other published series. Sayegh et al (26) and Brierly et al (4) reported similar results. In the present study, 68.2% of patients achieved 20/40 or better following surgery, which compares favorably with rates of 47% to 91% reported in the literature.
(22-30) Mahmood and Wagoner (22) found that 55 eyes (61.1%) achieved a BCVA of 20/40 or better, and Claesson et al (27) reported that 47% of patients with keratoconus achieved a BSCVA of 20/40 or better. A study by Funnell et al (28) reported that the majority (85%) of subjects achieved a binocular VA of 20/40 or better following surgery at 12 months. In addition, Lim et al (29) reported that 87% of keratoconic eyes achieved 20/40 or better following PKP, with a mean follow-up of 56.5 months.
The incidence of successful 20/40 VA was not significantly affected by graft rejections. Only 2 patients who had experienced an episode of rejection had a VA worse than 20/60. These findings may indicate that an adverse effect on VA cannot be attributed to a rejection episode that has been successfully treated.
In summary, PKP is associated with a good visual outcome and prognosis for graft survival with a low complication rate in eyes with keratoconus. 
